je.st
news
Data From Phase 3 Pivotal Studies Show Amgen's Novel...
2014-03-30 17:13:28| Biotech - Topix.net
Data From Two Separate Phase 3 Studies of Evolocumab , a PCSK9 Inhibitor, Presented in Late-Breaking Clinical Trials Session at ACC.14 - Data Add to the Three Pivotal Studies Presented Yesterday /PRNewswire/ -- Amgen today announced new detailed data from two Phase 3 pivotal studies that showed treatment with its novel investigational ... (more)
Tags: show
data
studies
phase
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||